These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 38075874)

  • 1. SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids.
    Stewart R; Yan K; Ellis SA; Bishop CR; Dumenil T; Tang B; Nguyen W; Larcher T; Parry R; Sng JJ; Khromykh AA; Sullivan RKP; Lor M; Meunier FA; Rawle DJ; Suhrbier A
    Front Microbiol; 2023; 14():1320856. PubMed ID: 38075874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omicron XBB.1.5 subvariant causes severe pulmonary disease in K18-hACE-2 mice.
    Elsharkawy A; Stone S; Guglani A; Patterson LD; Ge C; Dim C; Miano JM; Kumar M
    Front Microbiol; 2024; 15():1466980. PubMed ID: 39417078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host immune responses associated with SARS-CoV-2 Omicron infection result in protection or pathology during reinfection depending on mouse genetic background.
    Singh G; Warang P; García-Bernalt Diego J; Chang L; Bykov Y; Singh S; Pache L; Cuadrado-Castano S; Webb B; Garcia-Sastre A; Schotsaert M
    Res Sq; 2023 Nov; ():. PubMed ID: 38077015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron Variants in Mice and Hamsters.
    Case JB; Scheaffer SM; Darling TL; Bricker TL; Adams LJ; Harastani H; Trende R; Sanapala S; Fremont DH; Boon ACM; Diamond MS
    bioRxiv; 2023 May; ():. PubMed ID: 37205409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the role of glycans in Omicron sub-lineages XBB.1.5 and XBB.1.16 binding to host receptor using molecular dynamics and binding free energy calculations.
    Singh JK; Singh J; Srivastava SK
    J Comput Aided Mol Des; 2023 Nov; 37(11):551-563. PubMed ID: 37542610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-dependent acquisition of pathogenicity by SARS-CoV-2 Omicron BA.5.
    Imbiakha B; Ezzatpour S; Buchholz DW; Sahler J; Ye C; Olarte-Castillo XA; Zou A; Kwas C; O'Hare K; Choi A; Adeleke RA; Khomandiak S; Goodman L; Jager MC; Whittaker GR; Martinez-Sobrido L; August A; Aguilar HC
    Sci Adv; 2023 Sep; 9(38):eadj1736. PubMed ID: 37738347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice.
    Tarrés-Freixas F; Trinité B; Pons-Grífols A; Romero-Durana M; Riveira-Muñoz E; Ávila-Nieto C; Pérez M; Garcia-Vidal E; Perez-Zsolt D; Muñoz-Basagoiti J; Raïch-Regué D; Izquierdo-Useros N; Andrés C; Antón A; Pumarola T; Blanco I; Noguera-Julián M; Guallar V; Lepore R; Valencia A; Urrea V; Vergara-Alert J; Clotet B; Ballana E; Carrillo J; Segalés J; Blanco J
    Front Microbiol; 2022; 13():840757. PubMed ID: 35602059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5.
    Shuai H; Chan JF; Hu B; Chai Y; Yoon C; Liu H; Liu Y; Shi J; Zhu T; Hu JC; Hu YF; Hou Y; Huang X; Yuen TT; Wang Y; Zhang J; Xia Y; Chen LL; Cai JP; Zhang AJ; Yuan S; Zhou J; Zhang BZ; Huang JD; Yuen KY; To KK; Chu H
    EBioMedicine; 2023 Sep; 95():104753. PubMed ID: 37579626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Omicron BA.1 Challenge after Ancestral or Delta Infection in Mice.
    Baz M; Deshpande N; Mackenzie-Kludas C; Mordant F; Anderson D; Subbarao K
    Emerg Infect Dis; 2022 Nov; 28(11):2352-2355. PubMed ID: 36191630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Synthetic SARS-CoV-2-Derived T-Cell and B-Cell Peptide Cocktail Elicits Full Protection against Lethal Omicron BA.1 Infection in H11-K18-hACE2 Mice.
    Song Y; Hu H; Xiao K; Huang X; Guo H; Shi Y; Zhao J; Zhu S; Ji T; Xia B; Jiang J; Cao L; Zhang Y; Zhang Y; Xu W
    Microbiol Spectr; 2023 Mar; 11(2):e0419422. PubMed ID: 36912685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Three Variants of SARS-CoV-2 In Vivo Shows Host-Dependent Pathogenicity in Hamsters, While Not in K18-hACE2 Mice.
    Toomer G; Burns W; Garcia L; Henry G; Biancofiori A; George A; Duffy C; Chu J; Sides M; Muñoz M; Garcia K; Nikolai-Yogerst A; Peng X; Westfall L; Baker R
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Pathogenicity of SARS-CoV-2 Delta and Omicron Variants by Analyzing the Expression Patterns of Immune Response Genes in K18-hACE2 Transgenic Mice.
    Kuruppuarachchi KAPP; Jang Y; Seo SH
    Front Biosci (Landmark Ed); 2022 Nov; 27(11):316. PubMed ID: 36472114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Omicron XBB subvariants exhibit enhanced fusogenicity and substantial immune evasion in elderly population, but high sensitivity to pan-coronavirus fusion inhibitors.
    Xia S; Jiao F; Wang L; Yu X; Lu T; Fu Y; Huang Z; Li X; Huang J; Wang Q; Man Q; Xiong L; Jiang S; Lu L
    J Med Virol; 2023 Mar; 95(3):e28641. PubMed ID: 36890632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pathogenicity of BA.2.12, BA.5.2 and XBB.1 with the Delta variant in Syrian hamsters.
    Mohandas S; Shete A; Kumar A; Wakchaure K; Rai V; Mote C; Dighe H; Sarkale P; Gawande P; Yemul J; Suryawanshi A; Joshi Y; Yadav PD
    Front Microbiol; 2023; 14():1183763. PubMed ID: 37426033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum neutralization of SARS-CoV-2 Omicron BA.2, BA.2.75, BA.2.76, BA.5, BF.7, BQ.1.1 and XBB.1.5 in individuals receiving Evusheld.
    Zhao Q; Wang X; Zhang Z; Liu X; Wang P; Cao J; Liang Q; Qu J; Zhou M
    J Med Virol; 2023 Jul; 95(7):e28932. PubMed ID: 37403923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of spike in the pathogenic and antigenic behavior of SARS-CoV-2 BA.1 Omicron.
    Chen DY; Kenney D; Chin CV; Tavares AH; Khan N; Conway HL; Liu G; Choudhary MC; Gertje HP; O'Connell AK; Kotton DN; Herrmann A; Ensser A; Connor JH; Bosmann M; Li JZ; Gack MU; Baker SC; Kirchdoerfer RN; Kataria Y; Crossland NA; Douam F; Saeed M
    bioRxiv; 2023 Jan; ():. PubMed ID: 36263066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters.
    Halfmann PJ; Iwatsuki-Horimoto K; Kuroda M; Hirata Y; Yamayoshi S; Iida S; Uraki R; Ito M; Ueki H; Furusawa Y; Sakai-Tagawa Y; Kiso M; Armbrust T; Spyra S; Maeda K; Wang Z; Imai M; Suzuki T; Kawaoka Y
    Commun Biol; 2024 Mar; 7(1):331. PubMed ID: 38491227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization against Omicron sublineages (BA.2/BA.5/BQ.1.1/XBB/XBB.1.5) in bivalent BNT162b2-vaccinated HCWs with or without risk factors, or following BT infection with Omicron.
    Amano M; Otsu S; Uemura Y; Ichikawa Y; Matsumoto S; Higashi-Kuwata N; Matsushita S; Shimada S; Mitsuya H
    Sci Rep; 2023 Oct; 13(1):17404. PubMed ID: 37833390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-neutralization and viral fitness of SARS-CoV-2 Omicron sublineages.
    Xia H; Yeung J; Kalveram B; Bills CJ; Chen JY; Kurhade C; Zou J; Widen SG; Mann BR; Kondor R; Davis CT; Zhou B; Wentworth DE; Xie X; Shi PY
    Emerg Microbes Infect; 2023 Dec; 12(1):e2161422. PubMed ID: 36594261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023.
    Link-Gelles R; Ciesla AA; Roper LE; Scobie HM; Ali AR; Miller JD; Wiegand RE; Accorsi EK; Verani JR; Shang N; Derado G; Britton A; Smith ZR; Fleming-Dutra KE
    MMWR Morb Mortal Wkly Rep; 2023 Feb; 72(5):119-124. PubMed ID: 36730051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.